Bausch + Lomb’s New CEO Inks First Big Deal
Wall Street Journal
Eye-care company has agreed to pay $1.75 billion for Novartis’s dry-eye treatment Xiidra.
https://www.wsj.com/articles/bausch-lombs-ceo-inks-first-big-deal-since-return-5f2ec13
Understanding current events through the lenses of the past and future.
Wall Street Journal
Eye-care company has agreed to pay $1.75 billion for Novartis’s dry-eye treatment Xiidra.
https://www.wsj.com/articles/bausch-lombs-ceo-inks-first-big-deal-since-return-5f2ec13